Adverse events on the rise
This article was originally published in The Gray Sheet
Executive Summary
Medical device adverse event reports continue to increase, FDA says. In FY 2006, they rose to 210,706, surpassing the 176,351 reported in 2005. Susan Gardner, director of CDRH's Office of Surveillance & Biometrics, suggests that the increase could be due to the device industry's growth. During a Nov. 1 Regulatory Affairs Professionals Society webcast, Gardner noted that "the ratio or percent of deaths, malfunctions and injuries - in spite of increasing reports - remains about the same," adding that the "number of injuries is increasing somewhat in proportion to malfunctions." For 2006, there were 2,735 deaths, 119,070 injuries, 82,493 malfunctions, and 6,408 adverse events classified as "other." Stats for 2005 were 2,347 deaths, 100,158 injuries, 67,183 malfunctions, and 6,663 events classified as other...
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.